Ignite Creation Date:
2024-05-05 @ 9:24 PM
Last Modification Date:
2024-10-26 @ 10:03 AM
Study NCT ID:
NCT00873132
Status:
WITHDRAWN
Last Update Posted:
2013-06-19
First Post:
2009-03-30
Brief Title:
BTC Neuropsychological Database
Sponsor:
Duke University
Organization:
Duke University
Study Overview
Official Title:
BTC Neuropsychological DatabaseProspective Study
Status:
WITHDRAWN
Status Verified Date:
2013-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
No Funding
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Purpose and Objective
The purpose of this study is to collect data both retrospectively and prospectively by consent on subjects seen in the PRTBTC This information will be useful to the investigators to generate hypotheses for planning further psychosocial and medication intervention studies that will hopefully improve primary brain tumor patients QOL
The purpose of this study is to collect data both retrospectively and prospectively by consent on subjects seen in the PRTBTC This information will be useful to the investigators to generate hypotheses for planning further psychosocial and medication intervention studies that will hopefully improve primary brain tumor patients QOL
Detailed Description:
Study Activities and Population Group
Retrospective dates will be 3106 through the approval date for the prospective component of this study The data will be neurocognitive depression tumor-related overall quality of life QOL treatment and demographic variables The investigators research aims are to
compute correlations among these different variables
to test significant predictors of QOL The investigators also will conduct a retrospective review of all brain tumor patients evaluated at the neuropsychology clinic at the PRT-BTC from the date that this prospective study is approved back to 3202006
Data Analysis and RiskSafety Issues
The medical record review does not present any obvious source of risk or discomfort to patients and their families For both the retrospective and prospective components of the study as the data for the proposed study were already collected as a part of the standard of care at the Preston Robert Tisch Brain Tumor Center at Duke there are no additional risks to the study sample as a result of data collection
Retrospective dates will be 3106 through the approval date for the prospective component of this study The data will be neurocognitive depression tumor-related overall quality of life QOL treatment and demographic variables The investigators research aims are to
compute correlations among these different variables
to test significant predictors of QOL The investigators also will conduct a retrospective review of all brain tumor patients evaluated at the neuropsychology clinic at the PRT-BTC from the date that this prospective study is approved back to 3202006
Data Analysis and RiskSafety Issues
The medical record review does not present any obvious source of risk or discomfort to patients and their families For both the retrospective and prospective components of the study as the data for the proposed study were already collected as a part of the standard of care at the Preston Robert Tisch Brain Tumor Center at Duke there are no additional risks to the study sample as a result of data collection
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None